Kellerhals Carrard has advised Swiss biotech startup Alp Bio AG on all legal aspects of a USD 2.2 million pre-seed funding round led by Munich-based 42CAP, with participation from Venture Kick and strategic angel investors.
Tags :dx3
Nokia has appointed Emiliano Berti (pictured) as Lead Counsel with global responsibility for its Microwave Radio (MWR) division, effective 1 April 2026. The move places one of the company’s most experienced in-house lawyers at the helm
Bratschi has advised the developers and owners of the Aves Hotel as Revier Hospitality Group will take over the operations of the former Hotel Aves Arosa as of 1 November 2026. The firm supported the developers and
Bratschi advised PSP Swiss Property on the contractual negotiations in connection with the planned conversion of the «RED» office building at the Löwenbräu site in Zurich into a hotel with 173 rooms. Completion of
Bratschi advised the management of SSP Kälteplaner in connection with the structuring and execution of the company’s management buy-out. Headquartered in Oensingen, Switzerland, SSP Kälteplaner is an independent engineering firm specialising in
VIscher appointed managing associates Basile Walder, Elias Mühlemann and Luzius Zumstein to head the firm’s startup desk. The trio succeeds partners Christian Wyss, Damien Conus and Gian-Andrea Caprez, previous heads of the desk.
Charles Russell Speechlys expanded its swiss tax lineup with the appointment of Frédéric Ney (pictured) as a partner in Geneva. The tax specialist moves from Bär & Karrer’s Geneva office, where
Schellenberg Wittmer advised BASF — a chemical company whose core business includes chemicals, materials, industrial solutions and nutrition & care — on the sale of its optical brightening agent business to Catexel. The transaction encompasses the international
Vischer advised Burckhardt of Switzerland, a Basel-based specialist in perforation and fibrillation for technical textiles and plastic film processing, on its partnership with Indian manufacturer R.K. Texparts. The collaboration in question will consolidate part
Vischer advised FimmCyte, a Swiss biotech developing targeted immunotherapies for chronic fibro-inflammatory diseases, in connection with its research collaboration and option-to-license agreement with Gedeon Richter, a pharmaceutical company specialised in women’s health, with headquarters
